Medicare Enrolled
Dr. Vithalbhai Dhaduk, M.D.
Neurology · Dunmore, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dhaduk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhaduk?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dhaduk
Dr. Vithalbhai Dhaduk is a neurology specialist in Dunmore, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dhaduk performed 5,961 Medicare services across 3,142 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dhaduk received a total of $175,552 from 65 pharmaceutical and/or device companies across 1652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dhaduk is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in PA
$175,552 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,961
Medicare services
Top 6% in PA for neurology
3,142
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~298 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,878 | $85 | $162 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
735 | $91 | $290 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
712 | $9 | $18 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
367 | $10 | $30 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
366 | $70 | $260 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
362 | $93 | $285 |
| Autonomic nervous system testing with tilt This test evaluates the function of the sympathetic and parasympathetic nervous systems. It involves monitoring the patient for at least five minutes while they are tilted. |
362 | $115 | $285 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
223 | $159 | $361 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
223 | $103 | $361 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
176 | $216 | $1,359 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
128 | $196 | $360 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
128 | $108 | $359 |
| New patient office visit, complex (60-74 min) | 106 | $153 | $277 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
71 | $122 | $187 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
65 | $114 | $256 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
59 | $238 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$175,552
Total received (2018-2024)
Avg $25,079/year across 7 years
Top 6% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
1,652
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$144,869 (82.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,427 (9.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,256 (7.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$23,296
2023
$35,085
2022
$16,044
2021
$19,079
2020
$26,208
2019
$22,894
2018
$32,947
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$13,574
Eisai Inc.
$7,701
PFIZER INC.
$291
Lilly USA, LLC
$221
Alexion Pharmaceuticals, Inc.
$190
Neurocrine Biosciences, Inc.
$165
CATALYST PHARMACEUTICALS, INC.
$145
EMD Serono, Inc.
$142
MDD US Operations, LLC
$110
CSL Behring
$96
ARGENX US, INC.
$83
Biogen, Inc.
$61
Grifols USA, LLC
$55
Lundbeck LLC
$55
Kyowa Kirin, Inc.
$50
ACADIA Pharmaceuticals Inc
$48
Neurelis, Inc.
$42
Celgene Corporation
$42
Amgen Inc.
$34
UCB, Inc.
$33
Otsuka America Pharmaceutical, Inc.
$26
Ipsen Biopharmaceuticals, Inc
$24
Averitas Pharma Inc.
$20
TG Therapeutics, Inc.
$20
Amneal Pharmaceuticals LLC
$20
Genentech USA, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
SK Life Science, Inc.
$16
Top 3 companies account for 92.6% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$47,512
AbbVie Inc.
$26,803
EISAI INC.
$26,096
Allergan, Inc.
$17,912
ABBVIE INC.
$17,555
Supernus Pharmaceuticals, Inc.
$7,705
Sunovion Pharmaceuticals Inc.
$7,301
SK Life Science, Inc.
$4,690
MDD US Operations, LLC
$4,340
Genentech USA, Inc.
$1,794
PFIZER INC.
$1,593
Biogen, Inc.
$1,375
Alexion Pharmaceuticals, Inc.
$1,053
Neurocrine Biosciences, Inc.
$917
Novartis Pharmaceuticals Corporation
$894
Amgen Inc.
$690
EMD Serono, Inc.
$646
Lilly USA, LLC
$569
Teva Pharmaceuticals USA, Inc.
$541
Amneal Pharmaceuticals LLC
$540
Kyowa Kirin, Inc.
$414
CSL Behring
$387
Janssen Pharmaceuticals, Inc
$369
Avanir Pharmaceuticals, Inc.
$331
US WorldMeds, LLC
$317
E.R. Squibb & Sons, L.L.C.
$285
CATALYST PHARMACEUTICALS, INC.
$230
ARGENX US, INC.
$216
Biohaven Pharmaceuticals, Inc.
$210
UCB, Inc.
$190
Mallinckrodt Hospital Products Inc.
$173
Lundbeck LLC
$165
GENZYME CORPORATION
$157
Avion Pharmaceuticals
$129
Adamas Pharmaceuticals, Inc.
$123
Neurelis, Inc.
$120
Celgene Corporation
$99
Akcea Therapeutics, Inc.
$90
Upsher-Smith Laboratories LLC
$84
LivaNova USA, Inc.
$80
Catalyst Pharmaceuticals, Inc.
$60
ACADIA Pharmaceuticals Inc
$59
Abbott Laboratories
$57
Sumitomo Pharma America, Inc.
$57
Grifols USA, LLC
$55
Otsuka America Pharmaceutical, Inc.
$54
Acorda Therapeutics, Inc
$52
Horizon Therapeutics plc
$51
Allergan Inc.
$49
Bayer HealthCare Pharmaceuticals Inc.
$38
IMPEL PHARMACEUTICALS INC.
$36
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$32
Alnylam Pharmaceuticals Inc.
$31
SANOFI-AVENTIS U.S. LLC
$30
UPSHER-SMITH LABORATORIES LLC
$25
Ipsen Biopharmaceuticals, Inc
$24
Vanda Pharmaceuticals Inc.
$22
Averitas Pharma Inc.
$20
TG Therapeutics, Inc.
$20
Life Molecular Imaging Ltd
$17
AstraZeneca Pharmaceuticals LP
$15
Validus Pharmaceuticals LLC
$15
Axsome Therapeutics, Inc.
$14
Mitsubishi Tanabe Pharma America, Inc.
$14
Merz Pharmaceuticals, LLC
$13
Top 3 companies account for 57.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Banzel · Betaseron · Briviact · COLOGUARD DNA CAPTURE REAGENTS · DUOPA · Dhivy · Dysport · EMGALITY · Enspryng · Equetro · FIRDAPSE · FORTEO · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Gocovri · HETLIOZ · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEQEMBI · LYRICA · Leqembi · LifeVest · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PLEGRIDY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · Soliris · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VRAYLAR · VUMERITY · VYEPTI · VYVGART · Vimpat · XCOPRI · Xadago · Xeomin · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in PA.
Geographic Context
Neurologists within 10 mi
16
Per 100K population
7.4
County median income
$64,691
Nearest hospital
GEISINGER-COMMUNITY MEDICAL CENTER
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dhaduk is a clinical cardiology specialist, with above-average Medicare volume (top 6% in PA), with speaking/promotional industry engagement in the top 6% of PA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dhaduk experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dhaduk performed 1,878 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dhaduk receive payments from pharmaceutical companies?
Yes. Dr. Dhaduk received a total of $175,552 from 65 companies across 1,652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhaduk's costs compare to other neurologists in Dunmore?
Dr. Dhaduk's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhaduk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Dunmore
Browse neurologists in Dunmore ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in PA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in PA
Which PA neurologists receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology